Sipuleucel-T Immunotherapy for Castration-Resistant Prostate CancerPhilip W. Kantoff, Paul F. Schellhammer|New England Journal of Medicine|2010Cited by 5.5k
Gene expression correlates of clinical prostate cancer behaviorDinesh Singh, William R. Sellers, Phillip G. Febbo et al.|Cancer Cell|2002Cited by 2.5k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I. Scher, Andrew J. Armstrong, Michael J. Morris et al.|Journal of Clinical Oncology|2016Cited by 1.6k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate CancerPhilip W. Kantoff, Wayne R. Godfrey, Thomas Schuetz et al.|Journal of Clinical Oncology|2010Cited by 973
Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 StudyPhilip W. Kantoff, Nicholas J. Vogelzang, Susan Halabi et al.|Journal of Clinical Oncology|1999Cited by 893